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Abstract 
Although not uncommon, neonatal cholestatic jaundice 
is usually caused by congenital anatomical defects of the 
biliary tree or intrinsic liver pathology. We describe a case 
of persistent cholestatic jaundice in a six week old female 
infant caused by panhypopituitarism.  
To our knowledge this is the first report of 
hypopituitarism presenting with cholestatic jaundice in 
Malta. Prolonged obstructive jaundice in the neonatal 
period should be urgently investigated until a cause is 
found.  
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Introduction 
Neonatal jaundice is most frequently caused by 
unconjugated hyperbilirubinemia. However, 
conjugated hyperbilirubinemia is always a concern as 
it may be attributable to genetic, metabolic, infectious, 
and obstructive causes.
1
 Panhypopituitarism is a rare 
condition in childhood and does not usually present in 
the neonatal period. Congenital hypopituitarism may 
be caused by one of a number of genetic disorders 
(such as POU1F1 or PROP1 gene mutations, etc)
2
 or 
be part of a developmental defect involving the 
hypothalamus and/or pituitary gland (such as 
holoprosencephaly, interrupted pituitary stalk, septo-
optic dysplasia, etc). Both causes of congenital 
hypopituitarism may very rarely present as cholestatic 
jaundice in the neonatal period. 
Cholestatic jaundice in the neonate should be 
promptly and energetically investigated in an effort to 
exclude any underlying anatomical problem of the 
biliary tree which requires surgical correction before 
irreversible damage to the liver occurs. In the absence 
of any positive investigations suggesting a structural 
biliary problem or intrinsic liver pathology, further 
investigations should be performed to exclude an 
endocrine problem, such as hypothyroidism, cortisol 
insufficiency or growth hormone insufficiency. A 
combination of more than one such hormone 
insufficiency should alert the physician to the 
possibility of an underlying pituitary problem.  
 
Case report 
A six week old female infant presented to out 
patients with a history of prolonged jaundice. She was 
born at term by normal vaginal delivery following a 
normal uneventful pregnancy.  
The infant was seen at a well baby clinic the week 
before and following a suggestion that the jaundice 
might be of breast milk origin, the mother decided to 
stop breast feeding and changed to formula milk. At 
presentation weight gain was noted to be slow but 
sustained. The infant was moderately jaundiced and 
direct questioning to the colour of the stools revealed 
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that these were pale in colour. The liver and spleen were 
not enlarged. An initial bilirubin level showed a total 
bilirubin of 170umol/l (Normal value <17 umol/l) with a 
direct fraction of 130umol/l. The infant was admitted for 
further investigations of cholestatic jaundice.  
 
 
Initial total serum bilirubin 170 umol/l (<17umol/l) 
Direct bilirubin 130 umol/l 
ALT (Serum) 31  (5-33 U/l) 
Alkaline Phosphatase 780 (0-449 U/l) 
Gamma GT 84 (5-36 U/l) 
Full blood count Normal 
Free T4 9.3 (11-18 pmol/l) 
TSH 3.7 (0.3-3.0 mU/l) 
Lipid profile Normal 
Renal profile Normal 
Urine analysis Normal 
Urine Culture Normal 
Cortisol AM serum <27.6 (138-690 nmol/L) 
Prolactin level Normal 
Plasma amino acids  (Quantitative) Normal 
Alpha 1-Antitrypsin level Normal 
Alpha 1-Antitrypsin phenotype Normal 
Galactosaemia screen Normal 
Tyrosinaemia screen Normal 
IGF-1 <30ng/ml (48-313 ng/ml) 
INR 1.06 
APTT 1.51 
TORCH / Viral hepatitis screen Negative 
Table 1: List of initial investigations. 
 
 
On the ward her stools were noted to be pale and her 
urine dark. She was feeding well. Liver profile showed a 
normal alkaline phosphatase and alanine aminotransferase 
level (ALT) with a slightly raised gamma-glutamyl 
transferase (GGT) level. Ultrasound of the abdomen 
showed a normal liver echogenicity, no dilated bile ducts 
and a gall bladder. A HIDA  (Hepatobiliary Iminodiacetic 
Acid) scan following priming with phenobarbitone showed  
tracer  extractionnoted  from  the  blood  pool  with  very  
markedly  delayed  transit  into  the  bowel (Figure 1).     
Activity as  seen  in  the  transverse  colon  on  the  20-
hour  image  making a diagnosis of  of  biliary  atresia 
unlikely..  Further investigations are listed in Table 1. Over 
the next week her total and direct bilirubin levels remained 
raised. Repeat thyroid testing was performed in view of the 
persistently low serum concentration of FT4 associated 
with a non-significant elevation of serum TSH 
concentration. Serum cortisol and IGF-I concentrations 
were also found to be very low.  A glucagon stimulation 
test was performed to further assess anterior pituitary 
function. The stimulation test showed a very flat response 
in both growth hormone (peak concentration of 2.3 ug/l, 
normal values > 7ug/ml) and cortisol secretion (peak 
concentration of 97 nmol/l), confirming a diagnosis of 
panhypopituitarism.  The patient was started on oral 
hydrocortisone replacement (15 mg/m
2
/day) followed 
by oral thyroxine (25ug/day) and subcutaneous growth 
hormone (0.6mg/m
2
/day). Her jaundice improved and 
subsided following three full weeks of treatment. Liver 
profile returned to normal and stools became fully 
pigmented. An MRI scan showed a very small anterior 
pituitary gland, an undescended posterior pituitary and 
a very thin stalk consistent with pituitary hypoplasia. 
The optic chiasm was normal.  
Follow up at five months of age showed she is 
thriving well with increase in her growth parameters 
from the 3
rd
 percentile to the 50
th
 percentile for weight 
and height. 
 
 
 
Figure 1. HIDA scan at 10 minute and 20 hours showing 
delayed but definitive gastrointestinal activity 
 
 
Discussion 
The aetiology of neonatal cholestasis is vast. Intra 
and extra hepatic pathology may be responsible and 
urgency in investigation is important in order to 
identify pathologies, such as biliary atresia, that 
require surgical intervention within a limited time 
frame. The association of liver dysfunction with 
hypopituitarism was first suggested in 1956.
1
 
Cholestasis associated with hypopituitarism may occur 
at birth, together with or following physiological 
jaundice.
3
 The mechanisms of the development of 
jaundice in pituitary hormone insufficiency are unclear, 
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but it is known that thyroid hormone and cortisol affect the 
bile acid-independent bile flow.
4
 Cortisol can influence 
bile formation, reduce bile flow as has been observed in rat 
studies following adrenalectomy.
5 
Growth hormone has 
also been shown to modulate bile acid synthesis both in 
rats and humans
6,7
 and that GH is important for bile acid 
formation. All three hormones are important independently 
in bile acid formation and excretion. Although jaundice 
usually improves and disappears following a month of 
treatment with hormone replacement, it may follow a 
protracted course.
7, 8
 Ocular manifestations or seizures 
should suggest the possible association of septo-optic 
dysplasia.  
Delay in the resolution of jaundice has been previously 
reported and raised transaminase levels may take up to 
several months to return to normal.
7
  With hormone 
replacement patients normalize growth and liver function 
have an excellent quality of life but will require life long 
treatment.  
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